You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Overview

  • Product nameAnti-XAF1 antibodySee all XAF1 primary antibodies ...
  • Description
    Rabbit polyclonal to XAF1
  • Tested applicationsICC/IF, WB, IHC-P more details
  • Species reactivity
    Reacts with: Mouse, Rat, Human
  • Immunogen

    Synthetic peptide (Human) (within the last 35 amino acids of C terminal end).

  • Positive controlHuman spleen cell lysate.

Properties

  • FormLiquid
  • Storage instructionsStore at +4°C.
  • Storage bufferPreservative: 0.02% Sodium Azide
    Constituents: PBS
  • Concentration information loading...
  • PurityImmunogen affinity purified
  • Clonality Polyclonal
  • IsotypeIgG
  • Research Areas

Applications

Our Abpromise guarantee covers the use of ab17204 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
ICC/IF ICC/IF: Use at an assay dependent dilution. PubMed: 18485100
WB WB: Use a concentration of 0.5 - 2 µg/ml. Detects a band of approximately 32 kDa.Can be blocked with XAF1 peptide (305-317) (ab39906). A higher 50kDa band is present at times (lot dependent). This band is not blocked by the immunogen. We do not know the identity of this extra band.
IHC-P IHC-P: Use at an assay dependent concentration.

Target

  • FunctionSeems to function as a negative regulator of members of the IAP (inhibitor of apoptosis protein) family. Inhibits anti-caspase activity of BIRC4. Induces cleavage and inactivation of BIRC4 independent of caspase activation. Mediates TNF-alpha-induced apoptosis and is involved in apoptosis in trophoblast cells. May inhibit BIRC4 indirectly by activating the mitochondrial apoptosis pathway. After translocation to mitochondra, promotes translocation of BAX to mitochondria and cytochrome c release from mitochondria. Seems to promote the redistribution of BIRC4 from the cytoplasm to the nucleus, probably independent of BIRC4 inactivation which seems to occur in the cytoplasm. The BIRC4-XAF1 complex mediates down-regulation of BIRC5/survivin; the process requires the E3 ligase activity of BIRC4. Seems to be involved in cellular sensitivity to the proapoptotic actions of TRAIL. May be a tumor suppressor by mediating apoptosis resistance of cancer cells.
  • Tissue specificityWidely expressed. Expression is frequently down-regulated in cancer cell lines. Isoform 5 is widely expressed. Expressed in placenta (at protein level).
  • Sequence similaritiesContains 1 TRAF-type zinc finger.
  • Developmental stageSelectively expressed in third trimester placenta.
  • Cellular localizationNucleus and Cytoplasm. Nucleus. Mitochondrion. Found in the cytoplasm and nucleus of placental syncytiotrophoblasts. Translocates to mitochondria upon TNF-alpha treatment.
  • Target information above from: UniProt accession Q6GPH4 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Database links
  • Alternative names
      BIRC 4 binding protein antibodyBIRC4 binding protein antibodyBIRC4-binding protein antibody
      BIRC4BP antibodyHSXIAPAF 1 antibodyHSXIAPAF1 antibodyXAF 1 antibodyXAF1 antibodyXAF1_HUMAN antibodyXIAP associated factor 1 antibodyXIAP-associated factor 1 antibodyXIAPAF1 antibody
    see all

Anti-XAF1 antibody images

  • Lane 1 : Anti-XAF1 antibody (ab17204) at 0.5 µg/ml
    Lane 2 : Anti-XAF1 antibody (ab17204) at 1 µg/ml
    Lane 3 : Anti-XAF1 antibody (ab17204) at 2 µg/ml

    Lane 1 : Human spleen lysate
    Lane 2 : Human spleen lysate
    Lane 3 : Human spleen lysate


    Observed band size : 32 kDa (why is the actual band size different from the predicted?)


    Higher 50kDa band presence is lot dependent. This band is not blocked by the immunogen.
  • ab17204 at 2µg/ml staining XAF1 in human spleen tissue by IHC

  • ICC/IF image of ab17204 stained HeLa cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab17204, 5µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

References for Anti-XAF1 antibody (ab17204)

This product has been referenced in:
  • Long X  et al. XAF1 contributes to dengue virus-induced apoptosis in vascular endothelial cells. FASEB J 27:1062-73 (2013). Read more (PubMed: 23207547) »
  • Wang Y  et al. Targeted proteasome inhibition by Velcade induces apoptosis in human mesothelioma and breast cancer cell lines. Cancer Chemother Pharmacol 66:455-66 (2010). WB ; Human . Read more (PubMed: 19960346) »

See all 3 Publications for this product

Product Wall

Filter by Application

Filter by Species

Filter by Ratings

Application Western blot
Sample Rat Cell lysate - other (primary cortical neurons)
Loading amount 25 µg
Specification primary cortical neurons
Blocking step Other as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 1x
Username

Verified customer

Submitted May 09 2006

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"